Minerva Neurosciences, Inc. (NERV) Operating income 2016–2025
Minerva Neurosciences, Inc. (NERV) annual operating income history from SEC filings — each fiscal year as reported.
-$15.1MFY2025 · since FY2016: -$30.2M → -$15.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$15.1M | +30.9% |
| FY2024 | -$21.8M | +5.5% |
| FY2023 | -$23.1M | +8.4% |
| FY2022 | -$25.2M | +44.4% |
| FY2021 | -$45.4M | -2556.5% |
| FY2020 | $1.8M | +102.4% |
| FY2019 | -$75.9M | -46.7% |
| FY2018 | -$51.7M | -25.6% |
| FY2017 | -$41.2M | -36.4% |
| FY2016 | -$30.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More NERV financial trends
NERV RevenueNERV Net incomeNERV Net marginNERV Gross profitNERV Gross marginNERV Operating marginNERV Operating cash flowNERV Free cash flowNERV Capital expendituresNERV Return on equityNERV Stock buybacksNERV Dividends paidNERV Total assetsNERV Total liabilitiesNERV Shareholders’ equityNERV overview →